B potent, hematopoietic stem cell'.4 in the bone marrow of adult humans? Stages of B-cell maturation can be characterized by the rearrangement and expression of the Ig genes: and by the expression of surface antigens7
It is generally accepted that during B-cell differentiation the rearrangement of the Ig heavy chain gene precedes that of the light chain
The first genetic event in B lymphopoiesis is the recombination of a heavy chain diversity (D) gene segment with a joining (JH) segment, and the subsequent joining of this gene product to a variable (V,)-region segment. 6 If this process results in the production of a functional gene, a heavy chain protein is expressed in the cytoplasm." In humans, pre-B cells at this stage of differentiation are found in fetal liver, fetal bone marrow, and adult bone m a r r o~. '~-'~ The next major molecular event in B-cell lymphopoiesis is the recombination of an Ig light chain variable (V,)-region gene segment with a joining (JL) segment. Once this has occurred, a complete Ig molecule can be assembled and expressed on the cell surface. Due to the mechanism of allotype exclusion, a single B cell usually expresses only one Ig heavy chain.I5 Isotype exclusion results in a single B cell expressing either IgK or IgX light chain, but not b~t h . '~, '~~'~ It is apparent that during B-cell differentiation a series of surface antigens are sequentially expressed and lost as this pathway proceeds from an immature progenitor to a mature B cell, and finally to a terminally differentiated plasma cell. Studies of human B-lymphocyte surface antigens have identified CD19 (B4, Leu-12) as a lineagespecific marker for all B lymphocytes.I8 CD34 (My-10, HPCA-1) is a progenitor cell antigen associated with cells of the myeloid lineage and is present on the earliest recognizable B-lineage CDlO (CALLA, J5) is expressed on a subset of immature B cells and is found on most cases of common acute lymphoblastic leukemia (CALL)." As B cells mature they acquire CD20 (Bl, Leu-16): lose CD10, express IgM on the surface, and then acquire CD21 (B2, C3d receptor, CR,).'' When mature human B lymphocytes are activated, several antigens, including CD23 (Fce receptor, L~U -~O ) ,~~,~~ are expressed. Finally, terminal differentiation into Ig-secreting plasma cells is association with the loss of most B-cell antigens, the expression of antigens such as PCA-1," and the secretion of Ig.
In the adult bone marrow, B lymphopoiesis is under the control of soluble growth factors and accessory cells in the stroma. Most of the information regarding the regulation of this process comes from investigations of the murine system? In the human system, the lack of suitable assays has hampered the elucidation of the specific growth factor and stromal cell requirements for in vivo stimulation of B-cell mat~ration.2~ The phenotype and Ig gene rearrangement status of B-cell precursors in fetal liver and fetal bone marrow samples have been examined by first immortalizing the cells using Epstein-Barr virus tran~formation,~'~' and by cloning CD10+ CD19' and CD10+ CD19-fetal liver lymphoid ~e l l s .~~,~~ Inferences regarding normal B-cell progenitors and the control of differentiation have also been made from cloning fresh ALL sample^^^.^^ and from ALL-derived cell lines.37 In contrast to the differentiation of B-cell precursors, the control of mature human B-cell activation and terminal plasma cell differentiation have been well characteri~ed.~~-~' We have recently reported an experimental system that permits the clonal growth of normal, bone marrow B-lineage cells into Ig-secreting plasma cells.42 In
Immunofluorescence andflow cytometry. B-cell colony assay. Percoll-fractionated cells were cultured in the top layer of a double-agar B-cell colony assay?' Briefly, each layer consisted of 1 mL of 0.3% melted agar (Difco, Detroit, MI) in culture media supplemented with 10% to 20% phytohemagglutinin (HA15: Wellcome, Dartford, UK) stimulated human T-cellconditioned media (TCM); and 10 &mL Staphylococcus aureus (Cowan strain) protein A (SPA) (Pharmacia) and/or 20 pg/mL dextran sulphate (DXS) (Sigma, St Louis, MO). TCM was included as a source of growth factors, and SPA/DXS as a source of mitogen necessary for the induction of Ig secretion from mature B cells. The culture media used was Opti-MEM (GIBCODRL, Burlington, Canada) supplemented with 5% FBS (GIBCO), 50 U/mL penicillin, 50 pg/mL streptomycin (GIBCO), and 5 x m o l n 2-mercaptoethanol (GIBCO). After a 10-day incubation at 37°C in 5% CO,, each 35-mm culture dish was examined for the growth of B-lineage colonies.
B-lineage colonies were enumerated using a previously described colony plaque assay that allows the detection of colonies containing cells that secrete Ig." Briefly, the top layer of a double-agar culture was transferred onto a glass slide, dehydrated, and overlaid with plaquing mixture containing 50 p L SPA-coupled sheep red blood cells (SRBC) (Woodlyn Labs, Guelph, Canada) (diluted 1:7 in Hank's buffered salt solution [HBSS]), 25 pL guinea pig complement (GIBCO) (diluted 1:3 in HBSS), 25 pL rabbit antiserum raised against human Igs (Cappell, Teknika Corporation, West Chester, PA) (diluted 1:25 in HBSS), and 500 pL 0.5% agar (BiTek; Difco). After a 5-hour incubation at 3TC, plaques were scored in the following manner. The SRBC were lysed with a 5% acetic acid:95% ethanol solution, and the plaque-forming colonies were stained with Giemsa (Fluka Chemicals, Beuchs, Switzerland) and enumerated microscopically. Those colonies that were within plaques and which contained more than 20 cells were designated as B-cell colonies. The colony-plaquing technique ensures that the colonies detected were Ig-secreting B-cell colonies!' This is important because myeloid cells also clone under these assay conditions; and secondly, single, Ig-secreting cells remain viable during the incubation period.
Percoll-fractionated bone marrow cells were depleted of cells expressing CD19, CD34, CD10, CD20, CD21, CD23, PCA-1, or CD13 with immunomagnetic beadsM using a modification of a previously described method!s Cells, 2 x lo6 to 20 x lo6, at a concentration of 2.5 x lo7 cells/mL PBS, 2% FBS, were incubated for 30 minutes on ice with MoAb (60 ng/l x lo6 cells of anti-CD19 and -CD21; 125 ng/l X lo6 cells of anti-CD10, -CD20, -CD23, -CD34, and IgG, isotype; 250 ng/ 1 x lo6 cells anti-PCA-1 and isotypes IgG,, and IgG,,). The cells were then pelleted, washed with PBS, 2% FBS, and incubated for 45 minutes on ice with magnetic beads (M-450; 4 x 108/mL) coated with sheep anti-mouse IgG (Dynal; P&S Biochemicals, Gaithersburg, MD) on ice for 45 minutes. These beads were washed with at least 300 vol of PBS, 2% FBS before use to remove all traces of preservative. Magnetic beads were added to the cells at a ratio of 2 beads to 1 cell (or approximately 15 beads:l target cell). Following this incubation, 8 mL PBS, 2%FBS was added to each tube and the tubes were placed in a magnetic particle concentrator (MPC-1; Dynal; P&S Biochemicals) for 1 to 2 minutes. Positive cells, which were rosetted with magnetic beads, were immobilized on the side of the tube next to the magnet, while the negative cells were in suspension and could be removed by pipetting. These negative or depleted cells were pelleted and incubated a second time with magnetic beads. After another 45-minute incubation on ice, the negative cells were harvested and washed twice.
In all experiments the efficiency of this depletion procedure was assessed by immunofluorescence and flow cytometry. Depleted cells were incubated with F(ab'), goat anti-mouse IgG-PE alone, or Colonyplaque assay.
Depletion of B-lineage subpopulations.
For personal use only. Ig, secreted by cells in colonies growing in the top layer of a double-agar culture, was transferred onto nitrocellulose filters during an overnight incubation. These filters were washed for 1 hour in PBS containing 1% bovine serum albumin (BSA) (fraction V Sigma) and 0.05% Tween 20 (Fisher Scientific, Toronto, Canada) and then incubated with the appropriate biotinylated goat anti-human Ig MoAb for 1 hour at room temperature. The antibodies used were biotinylated anti-IgK (1:2,000) and anti-Igh (1:1,000). After washing in PBS, the filters were incubated for 1 hour with HRPO-conjugated extravidin (1:1,500; Sigma), washed, and developed for 5 minutes in a solution containing 4.4 mg luminol(5-amino-2,3-dihydro-1,4-phthalazinedione; Sigma), 10 mg 4-methylumbelliferone (Sigma), and 6 pL 30% hydrogen peroxide (Sigma) in a 0.1 mol/L Tris (pH 8.0) buffer. The filters were sealed in plastic bags and visualized by brief exposure (0.5 to 10 minutes) to X-ray film (XRP; Eastman Kodak, Rochester, NY).
To detect the secretion of a second Ig isotype from single colonies, the filters that were previously treated with a biotinylated antibody and developed were washed in a 0.1 mol/L sodium azide (Sigma) solution for 5 minutes to inactivate the bound peroxidase. These filters were then rinsed well in PBS, blocked for 15 minutes in 1% BLOTTO, and incubated for 1 hour with a second goat anti-human Ig MoAb. The antibodies used in this replicate blotting technique were coupled directly to peroxidase, and included goat anti-human IgK-HRPO (1:2,000) and goat anti-human Igh-HRPO (1:2,000). Positive colonies were visualized as above.
Enumeration of double IgK + A-producing colonies was accomplished by aligning the autoradiograph showing colonies positive for the first antibody (eg, IgK) with the autoradiograph showing colonies positive for the second antibody (eg, Igh). To reliably orient these two autoradiographs a marker of human plasma was placed in the corners of the filter before Ig transfer.
The specificity of the MoAbs used for protein blotting was determined previously4* using cell lines that secrete Ig of known isotypes. The sodium azide treatment was also previously shown to successfully remove all signals due to the HPRO bound to the first Replicate colony protein blotting.
antibody on the filter, and not to interfere with subsequent binding of a second antibody to the filter.
RESULTS

FACSCAN analysis of percoll-enriched bone marrow.
Percoll-fractionation of normal human bone marrow resulted in an enrichment in the percent of B-lineage cells,42 namely those expressing CD19, CD10, and CD20 surface antigens (data not shown). Plasma cells that expressed the PCA-1 antigen were more frequent in higher density percoll fractions.
Cells in percoll-enriched bone marrow samples (5.5% 2 2.8% of nucleated bone marrow cells4*) were heterogeneous in their forward-angle and side lightscattering characteristics. Greater than 95% of CD19' cells have been previously shown to be confined to a well-defined cluster,' which allowed the gating of cells for further immunofluorescence analysis. The cells within these gates constituted approximately 50% of the cells with a density of between 1.050 g/mL and 1.065 g/mL. The distribution of cells in percoll-enriched bone marrow samples expressing specific B-lineage antigens is shown in Table 1 . CD19' and CD20' cells fell almost exclusively within the population gated to include cells with low side and forward light-scatter properties. However, only a proportion of cells expressing CDlO or CD34 exhibited a lymphoid profile. Most of the PCA-1' plasma cells were not within the gated region.
Effect of depletion of B-lineage subpopulations on B-cell colony growth. The B-cell colony assay allows the clonal growth of B-lineage cells.4* To characterize the clonogenic cells, the input population was depleted of specific B-lineage subpopulations, as determined by surface antigen expression, before plating in the B-cell colony assay. In these experiments, the contribution of a specific subset of B-lineage cells was determined by comparing the plaqueforming colony growth of depleted populations with that of undepleted, isotype control populations. Depletion was achieved by the use of MoAbs and magnetic immunobeads. FACSCAN analysis showed that this procedure led to a depletion of greater than 95% of the relevant cells in all experiments presented. The removal of CD20+ cells from the input population led to a depletion of 51.3% 5 6 .0% (n = 8) of the number of resultant plaque-forming colonies when compared with isotype control cultures (Fig 1 and Table 2 ). During differentiation, CD20 is acquired after CD19 and CD10; therefore, this result suggests that more mature B-lineage that observed with CD20 depletion ( Table 2) . Table 2 . It is demonstrated that the depletion of CD19' cells from percoll-enriched bone marrow samples resulted in a reduction of 96.1% * 5.7% (n = 10) in the number of resultant plaque-forming colonies. This result indicates that the clonogenic cell in this assay is a B-lineage cell which expresses the B-cell-specific surface antigen, CD19.
The removal of CDlO+ cells from the input population led to a reduction in the growth of plaque-forming colonies by 51.5% ? 13.3% (n = 8) relative to isotype control cultures (Fig 1 and Table 2 ). CDlO is expressed on a subset of immature B-lineage cells, and is acquired after the expression of CD19 and before the expression of surface IgM. Therefore, the results of this depletion experiment suggest that these assay conditions allow CD10' B-cell was observed after the depletion of either plasma cells expressing PCA-1, or activated B cells expressing CD23, from percoll-enriched bone marrow samples in three experiments (Fig 1 and Table 2 ).
Some depletion of plaque-forming colonies was observed when CD34-cells were plated in the B-cell colony assay (Fig 1 and Table 2 ). This result was variable, with a range of 27% to 51% depletion of plaque-forming colonies in four experiments.
Monocytes and granulocytes express CD13 on their cell surface.% Depletion of CD13' cells from percoll-enriched bone marrow samples before plating in the B-cell colony assay did not significantly affect the number of resultant plaque-forming colonies in three experiments ( Table 2) .
Identification of colonies secreting both K and A Ig light chains. Replicate colony protein blotting experiments were performed to assess whether the culture conditions described allowed the clonal growth of Ig light chain uncommitted B-cell precursors. In these experiments, cultures were analyzed for colonies that simultaneously secreted both IgK and IgA. This experimental approach is based on the premise that a single colony containing some cells secreting IgK and others secreting IgA originated from a progenitor cell that was not yet committed to the expression of a particular Ig light chain. Figure 2 shows the positive signals obtained after replicate protein blotting with anti-IgK and anti-IgA MoAbs. It can be seen that the autoradiographs of the first and the second antibodies can be aligned, allowing the enumeration of double K + A-colonies by counting the number of times positive signals precisely overlap on both autoradiographs. Figure 2 and Table 3 demonstrate that no active, residual Percoll-enriched bone marrow samples were depleted of B-lineage subpopulations using MoAbs and magnetic immunobeads. These cells were then plated in the B-cell colony assay and resulting plaque-forming colonies enumerated. The percent depletion of plaque-forming colonies was calculated for each experiment and the mean, SEM (standard error of the mean), and the range of a series of experiments are presented in this table.
'Number of plaque-forming colonies was not significantly different (Student's t-test: 95% confidence interval) from the appropriate isotype control in each experiment. Replicate protein blotting. Percoll-enriched bone marrow cells were cultured in the 6-cell colony assay for 10 days. The Ig secreted from 6-cell colonies was transferred onto nitrocellulose filters and these filters were analyzed for IgK and Igh light chain isotype secretion using the replicate protein blotting technique. Autoradiographs produced with the first antibody (i) could be aligned to that of the second antibody (ii) by orienting the positive plasma marker signals in the corners of each filter. The first, biotinylated anti-human Ig antibodies used were anti-lgK (row A) and anti-lgh (rows B and C). Filters were then incubated with earavidin-HPRO and developed using the luminographic method (2-minute exposure) (column i). The same filters in each row were then treated with sodium azide and incubated with HPRO-conjugated anti-lgh (rows A and C ) or no antibody (row E), followed by luminographic development (2-minute exposure) (column ii). In row A, the white circles denote some of the signals that were positive for both IgK and Igh. Row B demonstrates that sodium azide treatment completely removed the signal caused by HRPO bound to the first antibody on the filter. In row C, it can be seen that this sodium azide inactivation process does not interfere with subsequent binding of a second antibody (anti-lgh) to the filter. In this example (C), greater than 90% of the Igh-positive signals detected with the first antibody (i) could be detected with a second anti-lgh antibody (ii).
HPRO from the first antibody signal remained after sodium azide inactivation, and that this treatment did not result in a significant loss of binding of a second antibody to the filter-bound Ig.
While positive signals could be easily enumerated, it should be pointed out that a drawback of the protein Table 3 , it can be seen that the number of double K + A-positive signals actually detected could not be accounted for solely by coincidence, because the maximum number of expected double positives because of chance overlaps was 9.5, whereas the number of observed K + A positives was 33. As the occurrence of these large positive signals is infrequent, it may be more realistic to use the average area of a positive signal for the calculation of the expected number of double positives arising because of coincidence. Thus, in the experiment shown in Table 3 , the average number of double positives Table 4) .
In these replicate protein blotting experiments, the ratio of IgK to IgA expression was maintained at approximately 60%:40%,4' as can be seen in Table 4 . This K:A ratio remained largely unchanged whether determined by singleor double-protein blotting ( Table 3) .
The frequency of Ig light chain uncommitted B-lineage cells that were able to generate plaque-forming colonies ranged from 1 in 1.42 x lo4 to 1 in 1.33 x lo3 percollenriched bone marrow cells.
The number of plaque-forming colonies was consistently higher than the number of observed K + A-producing colonies (Table 4 ) when the two were assessed in parallel. This result indicates that the clonogenic cell that gave rise to K + A-producing colonies is not the only cell type that can differentiate and proliferate into Ig secreting B-cell colonies in this assay. This observation is supported by the depletion experiments outlined above.
Light chain uncommitted B-lineage cells express CD19 and CD10. The preceding results suggest that the clonogenic cell that initiates K + A-producing colonies has an immature phenotype. This was verified by replicate protein blotting analysis of cultures in which the input population was Three concentrations of percoll-enriched bone marrow cells (5 x lo', 1 x lo5, and 2 x lo5) were cultured in the double-agar 8-cell colony assay.
After a 10-day incubation the lg secreted from colonies growing in the agar was transferred onto nitrocellulose filters. The filters were incubated with either anti-human Igr-biotin or anti-human IgA-biotin antibody, then extravidin-HPRO, and developed using the luminographic technique. The HPRO on the filters was inactivated and each filter was subsequently incubated with either anti-human IgA-HRPO or anti-human IgK-HRPO antibody, respectively, and developed. The mean number of observed single lgK, single IgA, and double IgK + IgA-positive (+ve) signals is given. The maximum number of double positives expected due to coincidence is also shown. The number of plaque-forming colonies (PFC) was estimated in parallel.
For together, these results suggest that the cell which gave rise to double IgK + IgA-producing colonies is an immature B-lineage cell that expresses CD19 and CDlO surface antigens but has not acquired the CD20 antigen. In addition, this implies that CD19 and CDlO antigens are acquired before Ig light chain commitment, whereas CD20 is not.
DISCUSSION
In this report we have determined that the culture conditions used in the previously described B-cell colony assay4' support the proliferation and differentiation of B-cell precursors, as well as more mature B lymphocytes. Specifically, we have characterized the clonogenic B-lineage cells from normal, adult, human bone marrow. The results presented here show that the culture conditions described allow the clonal growth and differentiation of both CD10' and CD20' B-lineage cells into Ig-secreting cells. Further, it is demonstrated that clonogenic cells which are uncommitted to Ig light chain expression have already acquired the CD19 and CD10, but not the CD20, surface antigens.
The expression of surface antigens by bone marrow B-lineage cells has enabled to divide these cells into maturation stages. The earliest recognizable B-lineage cells express HLA-DR, CD19, and possibly CD34. During the next stage these cells gain CDlO and lose CD34. Next CD20 is acquired, CDlO is lost, and surface IgM is expressed. More mature B cells express CD21, on activation acquire CD23, and after terminal differentiation .oooo
Percoll-enriched bone marrow samples were depleted of cells expressing CD19, CD20, or CDlO surface antigens. These depleted populations were plated in the double-agar B-cell colony assay and incubated for 10 days. The cultures (n = 8 replicates) were then assayed using the replicate protein blotting method to detect colonies containing both cells that secrete IgK and cells that secrete IgA. lsotype control cultures were set up and analyzed in parallel. The mean and the standard error of the mean (SEM) are given for four separate experiments. The Student's t-test was used to compare CD19-and CD20-cultures with the lgGl isotype control cultures; and CDlO-cultures to the IgG2b control cultures. The number of double kJK + A-secreting colonies was significantly reduced when the input population was depleted of CD19' cells or of CD10' cells.
to plasma cells express antigens such as PCA-1. To further characterize the clonogenic cells in the B-cell colony assay we chose to deplete bone marrow samples of B-lineage subpopulations before plating. Depletion, rather than positive enrichment, was selected because the binding of some B-lineage antibodies to their respective surface antigen has been reported to deliver either activation (CD20;' CD21,S1 CD2352) or inhibition (CD19,53 CD207) signals to the cell. Also, we observed that considerable cell death resulted from an overnight incubation of cells rosetted with immunobeads; and lastly, cell sorting by flow cytometry was not considered feasible due to the low frequency of relevant cells in the bone marrow, and the lengthy periods of time required for this procedure.
It was demonstrated that depletion of CD19' cells before plating in the B-cell colony assay led to an almost complete abolition of plaque-forming colony growth. Further experiments, in which the depletion of B-lineage subpopulations was combined with replicate protein blotting analysis of the resultant colonies, allowed us to correlate surface antigen expression with the status of Ig light chain commitment in clonogenic B-lineage cells. Depletion of CD10' or CD19' populations resulted in the elimination of double IgK + A-producing colonies, whereas depletion of CD20' cells did not affect the growth of these colonies. Thus, these experiments provide evidence that B-lineage cells that are not yet committed to the usage of a particular Ig light chain, express the CDlO surface antigen but do not express CD20. This suggests that B-lineage cells in the normal, adult bone marrow acquire the CD19 and CDlO surface antigens before Ig light chain commitment, whereas the CD20 antigen is expressed after this commitment event.
Replicate protein blotting analysis may provide a useful tool in future studies aimed at determining the effects of growth factors and stromal cells on the differentiation of Ig light chain uncommitted progenitor cells in vitro. Unfortunately, two drawbacks with this detection system should be kept in mind. Firstly, functional cells cannot be recovered after the detection procedure. Secondly, Ig-secreting cells are sustained during in vitro culture, as reported by others3' These single Ig-secreting cells also cause a positive signal on autoradiographs after protein blotting. Therefore, input cell numbers must be kept low to minimize coincidental overlap of signals and alignment of autoradiographs should be carefully performed.
The results presented here, together with our previous describe culture conditions that allow the clonal growth and differentiation of B-lineage cells, including immature CD10' cells, into Ig-secreting cells. Using this system it will be possible to investigate the direct effect of growth factors and stromal cells on human B-lineage colony precursors, and hence further our current understanding of normal, human B l y m p h o p~i e~i~.~~~~~~"~~~'~~~~~~ In addition, this assay allows the frequency of the responding cell to be determined. For example, the frequency of total B-cell colony progenitors that grow under the described culture conditions was previously estimated to be a maximum of 1 in 1 X lo3 (0.1%),42 while the maximum frequency of clonogenic cells initiating IgK + A-producing colonies was M.33 x lo3 (0.03%) percoll-enriched bone marrow cells in the experiments presented here. The normal, human B-cell colony assay may also prove useful for detecting B-lineage cells in bone marrow colonies of mixed lineages (CFU-mix), thereby affording a means for studying human pluripotent stem cells that are capable of giving rise to myeloid and T-cell as well as B lymphocytes. The expression of the CD34 antigen may be important for the study of such stem cells because (1) this antigen is expressed on early myeloid progenitor cells,'9363 (2) it is also expressed on B-cell precursors, and (3) the depletion experiments reported here indicate that CD34 is expressed on some of the clonogenic cells that give rise to plaque-forming colonies. Replicate RNA colony blotting4' will be an effective technique for studying multiple RNA transcripts in such single, multi-lineage colonies.
In summary, we have demonstrated that under these culture conditions, cells expressing CD19, CD10, and CD20 surface antigens are able to differentiate in vitro to form colonies containing cells that secrete Ig. In addition, we have shown that B-lineage cells uncommitted to Ig light chain expression have already acquired the CD19 and CD10, but not the CD20 surface antigens. Studies are ongoing to assess the regulatory influences of known growth factors and bone marrow stromal cells on normal human B lymphopoiesis using the B-cell colony assay.
